Medical research

Drew Weissman, Nobel-winning mRNA pioneer

Drew Weissman's decades of research into mRNA technology paved the way for COVID-19 vaccines, finally earning a Nobel prize for the physician-scientist.

Medications

Unlocking how the new Alzheimer's drug lecanemab works

Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be a main driver of the disease. ...

Medical research

Sickle cell disease needs more attention

The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs ...

Diseases, Conditions, Syndromes

Mapping anemia risk in preschool-age children in West Africa

In this week's PLoS Medicine, Ricardo Soares Magalhães and Archie Clements, from the University of Queensland, Brisbane, Australia, describe how they used national cross-sectional household-based demographic health surveys ...

page 7 from 27